The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Transmission of Extensively Drug-Resistant Tuberculosis in South Africa
Open accessAbstract
BACKGROUND: Drug-resistant tuberculosis threatens recent gains in the treatment of tuberculosis and human immunodeficiency virus (HIV) infection worldwide. A widespread epidemic of extensively drug-resistant (XDR) tuberculosis is occurring in South Africa, where cases have increased substantially since 2002. The factors driving this rapid increase have not been fully elucidated, but such knowledge is needed to guide public health interventions. METHODS: We conducted a prospective study involving 404 participants in KwaZulu-Natal Province, South Africa, with a diagnosis of XDR tuberculosis between 2011 and 2014. Interviews and medical-record reviews were used to elicit information on the participants' history of tuberculosis and HIV infection, hospitalizations, and social networks. Mycobacterium tuberculosis isolates underwent insertion sequence (IS)6110 restriction-fragment-length polymorphism analysis, targeted gene sequencing, and whole-genome sequencing. We used clinical and genotypic case definitions to calculate the proportion of cases of XDR tuberculosis that were due to inadequate treatment of multidrug-resistant (MDR) tuberculosis (i.e., acquired resistance) versus those that were due to transmission (i.e., transmitted resistance). We used social-network analysis to identify community and hospital locations of transmission. RESULTS: Of the 404 participants, 311 (77%) had HIV infection; the median CD4+ count was 340 cells per cubic millimeter (interquartile range, 117 to 431). A total of 280 participants (69%) had never received treatment for MDR tuberculosis. Genotypic analysis in 386 participants revealed that 323 (84%) belonged to 1 of 31 clusters. Clusters ranged from 2 to 14 participants, except for 1 large cluster of 212 participants (55%) with a LAM4/KZN strain. Person-to-person or hospital-based epidemiologic links were identified in 123 of 404 participants (30%). CONCLUSIONS: The majority of cases of XDR tuberculosis in KwaZulu-Natal, South Africa, an area with a high tuberculosis burden, were probably due to transmission rather than to inadequate treatment of MDR tuberculosis. These data suggest that control of the epidemic of drug-resistant tuberculosis requires an increased focus on interrupting transmission. (Funded by the National Institute of Allergy and Infectious Diseases and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Self-citationSouth African National HIV Prevalence, Incidence and Behaviour Survey, 2012
Shisana, O., Rehle, T. M., Simbayi, L. C., Zuma, K. K., Jooste, S. E., Zungu, N. P., Labadarios, D., & Onoya, D. (2014) · Cited by 1,190
Tuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 640
National Survey of Drug-Resistant Tuberculosis in China
Zhao, Y., Xu, S., Wang, L., Chin, D. P., Wang, S., Jiang, G., Xia, H., Zhou, Y., Li, Q., Ou, X., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108789 · Cited by 631
Worldwide Emergence of Extensively Drug-resistant Tuberculosis
Shah, N. S., Wright, A., Bai, G.-H., Barrera, L., Boulahbal, F., Martín-Casabona, N., Drobniewski, F., Gilpin, C., Havelková, M., Lepe, R., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1303.061400 · Cited by 583
Self-citationPearson, M. L., Jereb, J. A., Frieden, T. R., Crawford, J. T., Davis, B. J., Dooley, S. W., & Jarvis, W. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-191 · Cited by 546
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
Wells, C. D., Cegielski, J. P., Nelson, L. J., Laserson, K. F., Holtz, T. H., Finlay, A., Castro, K. G., & Weyer, K. (2007) · The Journal of Infectious Diseases · doi:10.1086/518665 · Cited by 483
Theron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M., Bara, W., Mungofa, S., Pai, M., Hoelscher, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62073-5 · Cited by 433
Falzon, D., Gandhi, N., Migliori, G. B., Sotgiu, G., Cox, H. S., Holtz, T. H., Hollm-Delgado, M.-G., Keshavjee, S., DeRiemer, K., Centis, R., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00134712 · Cited by 388
Self-citationGuerra-Assunção, J., Crampin, A., Houben, R., Mzembe, T., Mallard, K., Coll, F., Khan, P., Banda, L., Chiwaya, A., Pereira, R., et al. (2015) · eLife · doi:10.7554/elife.05166 · Cited by 257
Pietersen, E., Ignatius, E., Streicher, E. M., Mastrapa, B., Padanilam, X., Pooran, A., Badri, M., Lesosky, M., van Helden, P., Sirgel, F. A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62675-6 · Cited by 246
Walker, T. M., Lalor, M. K., Broda, A., Ortega, L. S., Morgan, M., Parker, L., Churchill, S., Bennett, K., Golubchik, T., Giess, A. P., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70027-x · Cited by 221
Yuen, C. M., Amanullah, F., Dharmadhikari, A., Nardell, E. A., Seddon, J. A., Vasilyeva, I., Zhao, Y., Keshavjee, S., & Becerra, M. C. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00322-0 · Cited by 201
Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007
Shah, N. S. (2008) · JAMA · doi:10.1001/jama.300.18.2153 · Cited by 201
Self-citationBasu, S., Andrews, J. R., Poolman, E. M., Gandhi, N. R., Shah, N. S., Moll, A., Moodley, P., Galvani, A. P., & Friedland, G. H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61636-5 · Cited by 201
Self-citationBryant, J. M., Schürch, A. C., van Deutekom, H., Harris, S. R., de Beer, J. L., de Jager, V., Kremer, K., van Hijum, S. A. F. T., Siezen, R. J., Borgdorff, M., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-110 · Cited by 197
Gelmanova, I. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.038331 · Cited by 170
Ritacco, V., Di Lonardo, M., Reniero, A., Ambroggi, M., Barrera, L., Dambrosi, A., Lopez, B., Isola, N., & de Kantor, I. N. (1997) · The Journal of Infectious Diseases · doi:10.1086/514084 · Cited by 163
Shah, N., Yuen, C. M., Heo, M., Tolman, A. W., & Becerra, M. C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit643 · Cited by 161
Self-citationAndrews, J. R., Gandhi, N. R., Moodley, P., Shah, N. S., Bohlken, L., Moll, A. P., Pillay, M., Friedland, G. H., & Sturm, A. W. (2008) · The Journal of Infectious Diseases · doi:10.1086/592991 · Cited by 148
Self-citationBecerra, M. C., Appleton, S. C., Franke, M. F., Chalco, K., Arteaga, F., Bayona, J. N., Murray, M. B., Atwood, S. S., & Mitnick, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61972-1 · Cited by 138
Gandhi, N. R., Weissman, D., Moodley, P., Ramathal, M., Elson, I., Kreiswirth, B. N., Mathema, B., Shashkina, E., Rothenberg, R., Moll, A. P., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis631 · Cited by 133
Self-citationGrandjean, L., Gilman, R. H., Martin, L., Soto, E., Castro, B., López, S., Coronel, J., Castillo, E. R., Alarcón, V., Lopez, V., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001843 · Cited by 129
Glynn, J. R., Guerra‐Assunção, J. A., Houben, R. M. G. J., Sichali, L., Mzembe, T., Mwaungulu, L. K., Mwaungulu, J. N., McNerney, R., Khan, P. Y., Parkhill, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132840 · Cited by 113
Moro, M. L., Gori, A., Errante, I., Infuso, A., Franzetti, F., Sodano, L., & Iemoli, E. (1998) · AIDS · doi:10.1097/00002030-199809000-00018 · Cited by 103
Loveday, M., Wallengren, K., Brust, J. C. M., Roberts, J. P., Voce, A. S., Margot, B., Ngozo, J., Master, I., Cassell, G. H., & Padayatchi, N. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0369 · Cited by 100
Self-citationMoro, M. L., Gori, A., Errante, I., et al. (1998) · PubMed · Cited by 96
A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa
Farley, J. E., Tudor, C., Mphahlele, M., Franz, K., Perrin, N., Dorman, S. E., & der Walt, M. L. V. (2011) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.10.0791 · Cited by 77
Epidemic Spread of Multidrug-Resistant Tuberculosis in Johannesburg, South Africa
Marais, B. J., Mlambo, C. K., Rastogi, N., Zozio, T., Duse, A. G., Victor, T. C., Marais, E., & Warren, R. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00200-13 · Cited by 75
Cited by
Furin, J., Cox, H., & Pai, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30308-3 · Cited by 873
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
The CRyPTIC Consortium and the 100, 0. G. P. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800474 · Cited by 500
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30024-8 · Cited by 361
Opportunities for natural products in 21st century antibiotic discovery
Wright, G. D. (2017) · Natural Product Reports · doi:10.1039/c7np00019g · Cited by 343
Metadata
- Authors
- Shah, N. S., Auld, S. C., Brust, J. C. M., Mathema, B., Ismail, N., Moodley, P., Mlisana, K., Allana, S., Campbell, A., Mthiyane, T., Morris, N., Mpangase, P., van der Meulen, H., Omar, S. V., Brown, T. S., Narechania, A., Shaskina, E., Kapwata, T., Kreiswirth, B., & Gandhi, N. R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-01-19
- Volume
- 376
- Issue
- 3
- Pages
- 243-253
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2577692590
- Cited by
- 281
- References
- 30
- FWCI
- 31.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.